Summary
Updated Aug 30, 2026
Arthur F. Golden is Director of Turn Therapeutics Inc. (TTRX). 6 SEC Form 4 filings on record going back to 2025, most recently on 8 June 2026. Most recent open-market trade: bought $34K of TTRX on 25 November 2025. Lifetime open-market purchases: $193K. Historical track record: 1/5 stars across 3 tracked purchases.
Recent Transactions
5Every recent SEC Form 4 transaction Arthur F. Golden has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Arthur F. Golden files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Abraham Chesed - $66K of TTRX open-market activity in the last 12 months
- Zuraiz Chaudhary - $50K of TTRX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Arthur F. Golden?
Arthur F. Golden is a corporate insider, tracked as Director of Turn Therapeutics Inc. (TTRX). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Arthur F. Golden submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Arthur F. Golden been buying or selling stock?
Recorded transactions: 3 open-market purchases ($193K) and 0 open-market sales across all tracked filings.
How accurate is Arthur F. Golden's historical track record?
Across 3 tracked purchases, Arthur F. Golden averaged -17.4% avg 30-day return with a 0% 30-day win rate. InsiderAlpha rates the track record at 1/5 stars.
Where can I see all of Arthur F. Golden's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Arthur F. Golden and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
